Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$663K Sell
25,000
-10,100
-29% -$258K 0.04% 122
2022
Q2
$738K Buy
35,100
+10,000
+40% +$252K 0.05% 125
2022
Q1
$730K Buy
+25,100
New +$589K 0.03% 138
2017
Q2
Sell
-10,000
Closed -$111K 313
2017
Q1
$111K Hold
10,000
0.01% 317
2016
Q4
$105K Hold
10,000
0.01% 297
2016
Q3
$86K Hold
10,000
0.01% 290
2016
Q2
$110K Hold
10,000
0.01% 282
2016
Q1
$128K Hold
10,000
0.01% 281
2015
Q4
$123K Hold
10,000
0.01% 285
2015
Q3
$122K Sell
10,000
-3,000
-23% -$40.6K 0.01% 297
2015
Q2
$186K Buy
13,000
+2,000
+18% +$31.6K 0.01% 317
2015
Q1
$153K Sell
11,000
-14,000
-56% -$209K 0.01% 328
2014
Q4
$410K Sell
25,000
-5,000
-17% -$85.8K 0.03% 207
2014
Q3
$530K Sell
30,000
-15,000
-33% -$294K 0.03% 187
2014
Q2
$882K Hold
45,000
0.05% 126
2014
Q1
$1.03M Buy
45,000
+15,000
+50% +$334K 0.07% 112
2013
Q4
$623K Hold
30,000
0.04% 170
2013
Q3
$542K Hold
30,000
0.04% 170
2013
Q2
$620K Buy
+30,000
New +$611K 0.05% 146

Other funds holding CCJ

R.H. Bluestein & Co's CCJ Position: Q3 2022 in Review

R.H. Bluestein & Co reduced its Cameco (CCJ) stake by 29% in Q3 2022, selling an estimated $258K and leaving 25,000 shares worth $663K. The position accounts for 0.04% of the portfolio, ranked #122.

R.H. Bluestein & Co first reported a position in CCJ in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.03M in Q1 2014. 469 funds tracked by Wall St. Rank hold CCJ as of Q3 2022.

  • R.H. Bluestein & Co held 25,000 shares of Cameco worth $663K as of Q3 2022.
  • R.H. Bluestein & Co sold 10,100 Cameco shares in Q3 2022, an estimated $258K.
  • Cameco made up 0.04% of R.H. Bluestein & Co's portfolio in Q3 2022, its #122 holding.
  • R.H. Bluestein & Co first reported a position in Cameco in Q2 2013 and has held it in 19 quarters since.
  • R.H. Bluestein & Co's Cameco position peaked at $1.03M in Q1 2014.
  • 469 funds tracked by Wall St. Rank held Cameco as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.